Exact Mass: 275.24603079999997

Crucigasterin 275

2-Methyl-12-(3-pyridyl)dodecanal

1,3-dideoxy-alpha-1-C-(8-hydroxyoctyl)mannojirimycin

C14H29NO4 (275.2096474)

2-phenyl-1,5,9-triazacyclotridecan-4-one

(5E,8Z)-3-(1-non-8-enyl)-5-((E)-1-prop-1-enyl)pyrrolizidine|3-(8-Nonenyl)-5-(1-propenyl)pyrrolizidine

ACMC-20mkiq

275C 3,5-Indolizidine (5Z,9Z)

275B Decahydroquinoline 2-epi-cis

2-(1-Hex-5-enyl)-5-(1-non-8-enyl)-pyrroline

phenylethylamide 275

(8S,Z)-6-((R,E)-2,5-dimethylhepta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol

(2S,5R)-2,5-di(pent-4-en-1-yl)decahydroquinoline

(3R,5S)-3-(hex-5-en-1-yl)-5-(pent-4-en-1-yl)octahydroindolizine

8-(but-3-en-1-yl)-5-(hept-6-en-1-yl)octahydroindolizine

(E)-8-ethyl-5-(non-5-en-1-yl)-1,2,3,5,8,8a-hexahydroindolizine

(5R,6R,8R,8aR)-6,8-dimethyl-5-((E)-nona-6,8-dien-1-yl)octahydroindolizine

(5R,6R,8R,8aR)-6,8-dimethyl-5-(non-8-yn-1-yl)octahydroindolizine

(3R,5S)-5-methyl-3-(non-8-yn-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

(3R,5S)-5-methyl-3-((E)-nona-6,8-dien-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

4-Piperidinecarboxamide,4-[(1-methylethyl)amino]-1-(phenylmethyl)-

Hexadiline

propiram

C15H33NO3 (275.24603079999997)

C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

Ametoctradin

5-ethyl-6-octyl-[1,2,3]triazolo[1,5-a]pyrimidin-7-amine

C15H25N5 (275.210985)

Tributylmethylammonium methyl carbonate

Anamorelin

tri-n-butyl-d27 phosphate

C12H18D9O4P (275.221181802)

2-NITRO-2-UNDECYL-1,3-PROPANEDIOL

C14H29NO4 (275.2096474)

2,4,6-Tri-t-butyl-nitrosobenzene

N,N-Diethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

C16H26BNO2 (275.2056486)

N-[2-(Diethylamino)ethyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide

2,4,6-tritert-butyl-N-methylaniline

4-Piperidinecarboxamide,1-(phenylmethyl)-4-(propylamino)-

C15H33NO3 (275.24603079999997)

3-(isodecyloxy)propylammonium acetate

Doxylaminephenyl-d5

C17H17D5N2O (275.20459009)

(1S,5R)-(-)-CIS-2-OXABICYCLO[3.3.0]OCT-6-EN-3-ONE

C17H29N3 (275.2361354)

N-(2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)PROPAN-1-AMINE

C16H26BNO2 (275.2056486)

17beta-estradiol-16,16,17-d3

C18H21D3O2 (275.196451934)

N-[3-(Dimethoxymethylsilyl)propyl]-1-piperazineethanamine

C12H29N3O2Si (275.2028934)

Piperphenidol

2-methoxy-4-(4-pyrrolidin-1-ylpiperidin-1-yl)aniline

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoate

cis-Parinarate

A straight-chain, unsaturated, long-chain fatty acid anion that is the conjugate base of cis-parinaric acid, arising from deprotonation of the carboxylic acid group.

All-cis-9,12-octadecadien-6-ynoic acid

Coniferonate

(1S,2R)-5-methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists

5-methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine

(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

N-(2-phenylethyl)decanamide

C15H33NO3 (275.24603079999997)

2-Aminopentadecane-1,3,4-triol

(6Z,9Z,12Z,15Z)-Octadecatetraenoate

C18H27O2 (275.2010942)

A polyunsaturated fatty acid anion that is the conjugate base of (6Z,9Z,12Z,15Z)-octadecatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

trans-parinarate

C18H27O2 (275.2010942)

A straight-chain, unsaturated fatty acid anion that is the conjugate base of trans-parinaric acid, arising from deprotonation of the carboxylic acid group.

octadecatetraenoate

C18H27O2. (275.2010942)

A fatty acid anion containing 18 carbons and four double bonds. Formed by deprotonation of the carboxylic acid group. Major species at pH 7.3.

5-methyl-3-(non-8-yn-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

n-[(2e,6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]guanidine

(2e,4e,8z,11z)-n-(2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid